These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21181521)

  • 41. Magnetic resonance spectroscopic imaging and volumetric measurements of the brain in patients with postcancer fatigue: a randomized controlled trial.
    Prinsen H; Heerschap A; Bleijenberg G; Zwarts MJ; Leer JW; van Asten JJ; van der Graaf M; Rijpkema M; van Laarhoven HW
    PLoS One; 2013; 8(9):e74638. PubMed ID: 24040301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study.
    Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls R; Petoumenos K; Taylor-Robinson SD; Emery S; Cooper DA;
    Clin Infect Dis; 2010 Mar; 50(6):920-9. PubMed ID: 20146627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression. Leukine/HIV Study Group.
    Angel JB; High K; Rhame F; Brand D; Whitmore JB; Agosti JM; Gilbert MJ; Deresinski S
    AIDS; 2000 Mar; 14(4):387-95. PubMed ID: 10770541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fatigue among HIV-infected patients in the era of highly active antiretroviral therapy.
    Henderson M; Safa F; Easterbrook P; Hotopf M
    HIV Med; 2005 Sep; 6(5):347-52. PubMed ID: 16156883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased glial metabolites predict increased working memory network activation in HIV brain injury.
    Ernst T; Chang L; Arnold S
    Neuroimage; 2003 Aug; 19(4):1686-93. PubMed ID: 12948723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A multicenter, randomized, double-blind, placebo-controlled trial of recombinant human interleukin-10 in HIV-infected subjects.
    Angel JB; Jacobson MA; Skolnik PR; Giordano M; Shapiro L; LeBeaut A; Greaves W; Fuchs AC
    AIDS; 2000 Nov; 14(16):2503-8. PubMed ID: 11101061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial.
    Rasmussen TA; McMahon JH; Chang JJ; Audsley J; Rhodes A; Tennakoon S; Dantanarayana A; Spelman T; Schmidt T; Kent SJ; Morcilla V; Palmer S; Elliott JH; Lewin SR
    Lancet HIV; 2018 May; 5(5):e221-e230. PubMed ID: 29643011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lithium therapy for human immunodeficiency virus type 1-associated neurocognitive impairment.
    Schifitto G; Zhong J; Gill D; Peterson DR; Gaugh MD; Zhu T; Tivarus M; Cruttenden K; Maggirwar SB; Gendelman HE; Dewhurst S; Gelbard HA
    J Neurovirol; 2009 Apr; 15(2):176-86. PubMed ID: 19306230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebral function in perinatally HIV-infected young adults and their HIV-uninfected sibling controls.
    Ashby J; Foster C; Garvey L; Wan T; Allsop J; Paramesparan Y; Taylor-Robinson SD; Fidler S; Winston A
    HIV Clin Trials; 2015; 16(2):81-7. PubMed ID: 25874990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.
    Cohen RA; Harezlak J; Gongvatana A; Buchthal S; Schifitto G; Clark U; Paul R; Taylor M; Thompson P; Tate D; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B;
    J Neurovirol; 2010 Nov; 16(6):435-44. PubMed ID: 20961212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents.
    ter Wolbeek M; van Doornen LJ; Kavelaars A; van de Putte EM; Schedlowski M; Heijnen CJ
    Brain Behav Immun; 2007 Nov; 21(8):1063-74. PubMed ID: 17544255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resting-state functional connectivity networks associated with fatigue in multiple sclerosis with early age onset.
    Stefancin P; Govindarajan ST; Krupp L; Charvet L; Duong TQ
    Mult Scler Relat Disord; 2019 Jun; 31():101-105. PubMed ID: 30954931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children.
    Palumbo PE; Raskino C; Fiscus S; Pahwa S; Fowler MG; Spector SA; Englund JA; Baker CJ
    JAMA; 1998 Mar; 279(10):756-61. PubMed ID: 9508151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection.
    Cozzi Lepri A; Katzenstein TL; Ullum H; Phillips AN; Skinhøj P; Gerstoft J; Pedersen BK
    AIDS; 1998 Sep; 12(13):1639-43. PubMed ID: 9764783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebral metabolites in HIV-infected children followed for 10 months with 1H-MRS.
    Keller MA; Venkatraman TN; Thomas MA; Deveikis A; Lopresti C; Hayes J; Berman N; Walot I; Ernst T; Chang L
    Neurology; 2006 Mar; 66(6):874-9. PubMed ID: 16567705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals.
    Premeaux TA; D'Antoni ML; Abdel-Mohsen M; Pillai SK; Kallianpur KJ; Nakamoto BK; Agsalda-Garcia M; Shiramizu B; Shikuma CM; Gisslén M; Price RW; Valcour V; Ndhlovu LC
    J Neurovirol; 2019 Apr; 25(2):150-161. PubMed ID: 30478799
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.
    D'Aquila RT; Hughes MD; Johnson VA; Fischl MA; Sommadossi JP; Liou SH; Timpone J; Myers M; Basgoz N; Niu M; Hirsch MS
    Ann Intern Med; 1996 Jun; 124(12):1019-30. PubMed ID: 8633815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
    Munderi P; Walker AS; Kityo C; Babiker AG; Ssali F; Reid A; Darbyshire JH; Grosskurth H; Mugyenyi P; Gibb DM; Gilks CF;
    HIV Med; 2010 May; 11(5):334-44. PubMed ID: 20136661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Magnetic Resonance Spectroscopy Study of Lovastatin for Treating Bipolar Mood Disorder: A 4-Week Randomized Double-Blind, Placebo- Controlled Clinical Trial.
    Lotfi M; Shafiee S; Ghanizadeh A; Sigaroudi MO; Razeghian L
    Recent Pat Inflamm Allergy Drug Discov; 2017; 10(2):133-141. PubMed ID: 27804862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.